Eye disease biomarker
AssigneeOsaka University
InventorsKohji Nishida, Atsushi Kumanogoh, Noriyasu Hashida
Life of this patent
Estimating the term…
Abstract
The principal purpose of the present invention is to provide a biomarker that makes it possible to conveniently and accurately assess corneal or conjunctival disease, and can use lacrimal fluid as the sample thereof. In addition, a main object of the present invention is to provide a biomarker that makes it possible to conveniently and accurately evaluate central serous chorioretinopathy. The present invention also provides a diagnostic kit containing a reagent capable of detecting the biomarker, and a diagnosis method that uses the biomarker. It is possible to use mitochondrial DNA included in lacrimal fluid as the biomarker for corneal or conjunctival disease.
Claims11
A biomarker for corneal or conjunctival disease which comprises mitochondrial DNA contained in lacrimal fluid.
A biomarker of central serous chorioretinopathy which comprises mitochondrial DNA contained in serum.
Dependencies are inferred from the claim text.